The objective of this model is to assess the cost-effectiveness of different screening strategies for cardiovascular disease in Spain. To estimate the risk of each individual, both the Framingham risk
Sensitivity to selected parameters of the incremental cost-effectiveness ratio (ICER) of replacing clinical diagnosis of malaria by rapid diagnostic tests in public health centres in Kintampo District
Summary results of the cost-effectiveness model comparing the Febrile Antigen Brucella Agglutination Test (FBAT) with the Rose Bengal Test (RBT) in the three scenarios modelled.
